study of carboplatin plus nivolumab in metastatic triple-negative breast cancer
Published 5 years ago • 1.3K plays • Length 7:40Download video MP4
Download video MP3
Similar videos
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
3:41
what is triple-negative breast cancer? | dana-farber cancer institute
-
1:03:16
triple negative breast cancer | dana-farber cancer institute
-
1:56
dr. eric winer on carboplatin and/or bevacizumab in triple-negative breast cancer
-
56:00
metastatic breast cancer forum 2018: triple negative breast cancer | dana-farber cancer institute
-
1:06:13
metastatic breast cancer forum 2017, triple negative breast cancer | dana-farber cancer institute
-
2:33
breast cancer: young mother embraces life | dana-farber cancer institute
-
1:15
the value of early diagnosis in amyloidosis and the impact of a delayed diagnosis for patients
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
1:41
dana-farber cancer institute | ian krop, md, phd, at sabcs 2020
-
2:01
ascogu24: xiao wei, md on tps244 | dana-farber cancer institute
-
2:21
how immunotherapy might be effective for triple-negative breast cancer
-
5:42
study of saci-io for triple negative metastatic breast cancer
-
7:43
study of abemaciclib for patients with rb-positive, triple negative metastatic breast cancer
-
18:38
breast cancer esmo 2024 highlights: key studies discussed natalee, keynote 522, destiny-breast12
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
4:42
study of screening mri of the brain in metastatic breast cancer or inflammatory breast cancer
-
21:39
new research in metastatic breast cancer | sabcs 2019
-
1:26
treating triple negative breast cancer